Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview. | Stem Cells Int | 2022 | 35721599 | PubTator, text mining | PubMed |
| Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents. | Bioorg Med Chem Lett | 2022 | 35718104 | PubTator, text mining | PubMed |
| Astrocyte ethanol exposure reveals persistent and defined calcium response subtypes and associated gene signatures. | J Biol Chem | 2022 | 35716779 | PubTator, text mining | PubMed |
| A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients. | Front Oncol | 2022 | 35712480 | PubTator, text mining | PubMed |
| Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia. | Cell Death Dis | 2022 | 35710782 | PubTator, text mining | PubMed |
| TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers. | Nucleic Acids Res | 2022 | 35687133 | PubTator, text mining | PubMed |
| Case Report: Long-Term Treatment and Follow-Up of Kleefstra Syndrome-2. | Front Pediatr | 2022 | 35685914 | PubTator, text mining | PubMed |
| Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis. | Cancers (Basel) | 2022 | 35681635 | PubTator, text mining | PubMed |
| Across Dimensions: Developing 2D and 3D Human iPSC-Based Models of Fragile X Syndrome. | Cells | 2022 | 35681419 | PubTator, text mining | PubMed |
| Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors. | Int J Cancer | 2022 | 35666536 | PubTator, text mining | PubMed |
| Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms. | Cancer Imaging | 2022 | 35659779 | PubTator, text mining | PubMed |
| The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes. | Cell Biosci | 2022 | 35659740 | PubTator, text mining | PubMed |
| Effects of novel glucose-lowering drugs on the lipid parameters: A systematic review and meta-analysis. | Ann Med Surg (Lond) | 2022 | 35637990 | PubTator, text mining | PubMed |
| Ethanol Induces Secretion of Proinflammatory Extracellular Vesicles That Inhibit Adult Hippocampal Neurogenesis Through G9a/GLP-Epigenetic Signaling. | Front Immunol | 2022 | 35634322 | PubTator, text mining | PubMed |
| Anti-Cancerous Potential of Polysaccharides Derived from Wheat Cell Culture. | Pharmaceutics | 2022 | 35631686 | PubTator, text mining | PubMed |
| Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. | Biomolecules | 2022 | 35625579 | PubTator, text mining | PubMed |
| Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial. | J Pineal Res | 2022 | 35619221 | PubTator, text mining | PubMed |
| Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma. | Int J Nanomedicine | 2022 | 35611214 | PubTator, text mining | PubMed |
| Cross-Talk Between Histone Methyltransferases and Demethylases Regulate REST Transcription During Neurogenesis. | Front Oncol | 2022 | 35600406 | PubTator, text mining | PubMed |
| Genetic investigation of syndromic forms of obesity. | Int J Obes (Lond) | 2022 | 35597848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=29